Mukka Proteins (MUKKA) — Annual Report

1 Annual Report 🔴 High Importance Neutral 📄 PDF

📢 Key Event
Intimation of dispatch of letter to shareholders with unregistered email addresses.

💡 Investor Takeaway
Shareholders must register their email addresses to receive future communications and access the annual report.

Mukka Proteins Limited announced on 18 August 2026 that it is sending a letter to shareholders with unregistered email addresses, providing a weblink to access the FY 2025-26 Annual Report and details of the 10 September 2026 AGM via video conference, urging email registration and KYC updates.

2 Annual Report 🔴 High Importance Neutral 📄 PDF

📢 Key Event
16th AGM scheduled for 10th September 2026 via video conferencing with e-voting from 7th-9th September 2026

🔄 What Changed
44% consolidated revenue growth to ₹14,494.53 million in FY26; ₹570.86 million PAT; ₹474.89 crore leachate treatment contract; target of ₹3,000 crore revenue by FY30

🔮 What's Next
Target ₹3,000 crore revenue by FY30; expansion into Oman and Sri Lanka; waste-to-value projects; diversification into alternate proteins

💡 Investor Takeaway
Strong growth in revenue and profit with strategic expansion into waste management and insect protein, but elevated leverage and execution risks in new markets require monitoring

Mukka Proteins Limited announced its 16th AGM on 10th September 2026 via video conferencing, with e-voting open from 7th-9th September 2026 (cut-off 3rd September). The filing details board appointments, financial performance, strategic expansion into waste management and insect protein, sustainability initiatives, and governance practices. Key financials include 44% consolidated revenue growth to ₹14,494.53 million in FY26, ₹570.86 million PAT, and ₹474.89 crore leachate treatment contract. The company targets ₹3,000 crore revenue by FY30 through diversification and international expansion.

📊 Stock Analysis — MUKKA ✨ Ask AI About This

About Mukka Proteins Limited (MUKKA)

Fast Moving Consumer Goods · FMCG · Listed on NSE

Market Cap: ₹800.4 Cr P/E: 11.6 ROE: 16.8% ROCE: 17.9%

View full MUKKA stock details →

📡 Get AI alerts when MUKKA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MUKKA — Free

💡 Ask AI about this filing

"What is Mukka Proteins' FY2025-26 revenue?" "How does the AGM voting process work via video conference?" "What are the company's dividend plans for FY2025-26?"

Ask AI Free →

📊 More MUKKA filings

See all MUKKA filings →

🔥 Also filed on 18 August 2026

MURUDCERA Murudeshwar Ceramics Limited Annual Report LUXIND Lux Industries Limited Corporate Action MMP MMP Industries Limited Corporate Action VADILALIND Vadilal Industries Limited Corporate Action ONESOURCE Onesource Specialty Pharma Limited Announcement LUXIND Lux Industries Limited Annual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MUKKA files new disclosures

Track MUKKA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MUKKA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd

Mukka Proteins Limited (MUKKA) — FY26 Annual Report | 18 August 2026(2 announcements)

About Mukka Proteins Limited (MUKKA)

📡 Get AI alerts when MUKKA files next

💡 Ask AI about this filing

📊 More MUKKA filings

🔥 Also filed on 18 August 2026